Skip to main content

Table 1 General, demographic, and clinical findings in subjects with acute ischemic stroke and in subjects without ischemic stroke

From: HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

Variables Subjects with acute ischemic stroke (n 116) Subjects without acute ischemic stroke (n 66) p
Sex (M/F) (n) 59/57 29/37 0.43
Age (years) (mean ± ds) 75.5 ± 11.6 73.7 ± 10.7 0.28
Diabetes (n/%) 48 (41.37) 30 (45.4) 0.62
Hypertension (n/%) 103 (87.9) 53 (80) 0.12
Hypercholesterolaemia (n/%) 41 (35.34) 27 (40.90) 0.51
Hypertriclyceridaemia (n/%) 26 (22.41) 19 (28.78) 0.32
Atrial fibrillation (n/%) 53 (45.68) 28 (42.46) 0.67
Previous stroke (n/%) 56 (48.27) 12 (18.18) < 0.0001
Glucose blood levels (mmol/L) 7.99 ± 3.27 6.05 ± 1.91 < 0.0001
SBP (mm/Hg) (mean ± ds) 15 l.4 ± 27.4 132.1 ± 11.4 < 0.0001
DBP (mm/Hg) (mean ± ds) 82.05 ± 14.43 78.8 ± 6.6 0.094
WBC (mean ± ds) 9448.7 ± 4978.17 7208.7 ± 2141.6 < 0.0001
Neutrophil (%) (mean ± ds) 72.3 ± 10.7 61.87 ± 9.5 0.32
ESR (mm/h) (mean ± ds) 29.07 ± 17.5 14.7 ± 9.16 < 0.0001
CRP (mg/dL) (mean ± ds) 3.84 ± 5.56 1.7 ± 1.6 0.004
TOAST subtype
 LAAS 45 (38.8)   
 Lacunar 27 (23.3)   
 CEI 40 (34.5)   
 ODE 4 (3.4)   
NIHSS (mean ± sd)    
SSSS (mean ± sd)    
CD4+ cells (%) (mean ± sd) 50.21 ± 8.31 34.12 ± 6.81 < 0.0001
CD4+CD28− (%) (mean ± sd) 5.70 ± 2.33 2.78 ± 0.93 < 0.0001
TNF-α (pg/ml) (mean ± sd) 18.7 ± 3.28 12.34 ± 4.54 0.035
IL-6 (pg/ml) (mean ± sd) 22.10 ± 12.21 4.22 ± 1.44 < 0.0001
  1. SBP systolic blood pressure, DBP diastolic blood pressure, WBC white blood cell, ESR erythrocyte sedimentation rate, CRP C-reactive protein, LAAS large artery atherosclerotic stroke, CEI cardioembolic infarct, ODE other determined etiology, NIHSS National Institutes of Health Stroke Scale, SSS Scandinavian Stroke Scale Score, CD4+ cluster of differentiation 4, CD28− cluster of differentiation 28 null cell, TNF-α tumor necrosis factor alfa, IL-6 interleukin-6